Literature DB >> 33413322

Establishment of a genetically engineered chicken DF-1 cell line for efficient amplification of influenza viruses in the absence of trypsin.

Kelly Chungu1, Young Hyun Park1, Seung Je Woo1, Su Bin Lee1, Deivendran Rengaraj1, Hong Jo Lee1, Jae Yong Han2.   

Abstract

BACKGROUND: The initial step of influenza infection is binding of the virus to specific sialic acid receptors expressed by host cells. This is followed by cell entry via endocytosis. Cleavage of the influenza virus hemagglutinin (HA) protein is critical for infection; this is performed by host cell proteases during viral replication. In cell culture systems, HA is cleaved by trypsin added to the culture medium. The vast majority of established cell lines are mammalian.
RESULTS: In the present study, we generated genetically engineered chicken DF-1 cell lines overexpressing transmembrane protease, serine 2 (TMPRSS2, which cleaves HA), ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3GAL1, which plays a role in synthesis of α-2,3 linked sialic acids to which avian-adapted viruses bind preferentially), or both. We found that overexpression of TMPRSS2 supports the virus life cycle by cleaving HA. Furthermore, we found that overexpression of ST3GAL1 increased the viral titer. Finally, we showed that overexpression of both TMPRSS2 and ST3GAL1 increased the final viral titer due to enhanced support of viral replication and prolonged viability of the cells. In addition, overexpression of these genes of interest had no effect on cell proliferation and viability.
CONCLUSIONS: Taken together, the results indicate that these engineered cells could be used as a cell-based system to propagate influenza virus efficiently in the absence of trypsin. Further studies on influenza virus interactions with chicken cell host factors could be studied without the effect of trypsin on cells.

Entities:  

Keywords:  Avian influenza virus; Chicken; DF-1 cell; Proteases; Sialic acid

Year:  2021        PMID: 33413322      PMCID: PMC7792337          DOI: 10.1186/s12896-020-00663-6

Source DB:  PubMed          Journal:  BMC Biotechnol        ISSN: 1472-6750            Impact factor:   2.563


  26 in total

Review 1.  Current and next generation influenza vaccines: Formulation and production strategies.

Authors:  Peter C Soema; Ronald Kompier; Jean-Pierre Amorij; Gideon F A Kersten
Journal:  Eur J Pharm Biopharm       Date:  2015-06-03       Impact factor: 5.571

2.  [Calculation of the index of acute toxicity by the method of linear regression. Comparison with the method of "Karber and Behrens"].

Authors:  H J Gilles
Journal:  Eur J Toxicol Environ Hyg       Date:  1974 Mar-Apr

3.  Generation of a High-Growth Influenza Vaccine Strain in MDCK Cells for Vaccine Preparedness.

Authors:  Eun-Ha Kim; Hyeok-Il Kwon; Su-Jin Park; Young-Il Kim; Young-Jae Si; In-Won Lee; Se Mi Kim; Soo-In Kim; Dong-Ho Ahn; Young Ki Choi
Journal:  J Microbiol Biotechnol       Date:  2018-06-28       Impact factor: 2.351

4.  Trypsin promotes efficient influenza vaccine production in MDCK cells by interfering with the antiviral host response.

Authors:  Claudius Seitz; Britta Isken; Björn Heynisch; Maria Rettkowski; Timo Frensing; Udo Reichl
Journal:  Appl Microbiol Biotechnol       Date:  2011-09-14       Impact factor: 4.813

5.  Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors.

Authors:  Eva Böttcher-Friebertshäuser; Catharina Freuer; Frank Sielaff; Sarah Schmidt; Markus Eickmann; Jennifer Uhlendorff; Torsten Steinmetzer; Hans-Dieter Klenk; Wolfgang Garten
Journal:  J Virol       Date:  2010-03-17       Impact factor: 5.103

6.  TMPRSS2 and TMPRSS4 facilitate trypsin-independent spread of influenza virus in Caco-2 cells.

Authors:  Stephanie Bertram; Ilona Glowacka; Paulina Blazejewska; Elizabeth Soilleux; Paul Allen; Simon Danisch; Imke Steffen; So-Young Choi; Youngwoo Park; Heike Schneider; Klaus Schughart; Stefan Pöhlmann
Journal:  J Virol       Date:  2010-07-14       Impact factor: 5.103

Review 7.  Cell-based influenza vaccines: progress to date.

Authors:  Jennifer M Audsley; Gregory A Tannock
Journal:  Drugs       Date:  2008       Impact factor: 9.546

8.  Sequence specificity of furin, a proprotein-processing endoprotease, for the hemagglutinin of a virulent avian influenza virus.

Authors:  J A Walker; S S Molloy; G Thomas; T Sakaguchi; T Yoshida; T M Chambers; Y Kawaoka
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

9.  Host-Specific Restriction of Avian Influenza Virus Caused by Differential Dynamics of ANP32 Family Members.

Authors:  Young Hyun Park; Kelly Chungu; Su Bin Lee; Seung Je Woo; Ho Yeon Cho; Hong Jo Lee; Deivendran Rengaraj; Ji-Ho Lee; Chang-Seon Song; Jeong Mook Lim; Jae Yong Han
Journal:  J Infect Dis       Date:  2020-01-01       Impact factor: 5.226

10.  Characterization of influenza virus sialic acid receptors in minor poultry species.

Authors:  Brian Kimble; Gloria Ramirez Nieto; Daniel R Perez
Journal:  Virol J       Date:  2010-12-09       Impact factor: 4.099

View more
  2 in total

1.  Chicken blastoderms and primordial germ cells possess a higher expression of DNA repair genes and lower expression of apoptosis genes to preserve their genome stability.

Authors:  Deivendran Rengaraj; Sohyoung Won; Kyung Min Jung; Seung Je Woo; Haerang Lee; Young Min Kim; Heebal Kim; Jae Yong Han
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

2.  Dual RNA-Seq of H5N1 Avian Influenza Virus and Host Cell Transcriptomes Reveals Novel Insights Into Host-Pathogen Cross Talk.

Authors:  Qiao Wang; Zixuan Wang; Jin Zhang; Qi Zhang; Maiqing Zheng; Jie Wen; Guiping Zhao; Qinghe Li
Journal:  Front Microbiol       Date:  2022-04-12       Impact factor: 6.064

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.